BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16279697)

  • 1. [FGF-23 in primary and secondary hyperparathyroidisms].
    Imanishi Y; Kobayashi K
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():539-44. PubMed ID: 16279697
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of secondary hyperparathyroidism.
    Slatopolsky E; Delmez JA
    Miner Electrolyte Metab; 1995; 21(1-3):91-6. PubMed ID: 7565472
    [No Abstract]   [Full Text] [Related]  

  • 3. FGF23 and mineral metabolism, implications in CKD-MBD.
    Rodríguez M; López I; Muñoz J; Aguilera-Tejero E; Almaden Y
    Nefrologia; 2012 May; 32(3):275-8. PubMed ID: 22592418
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications.
    Damasiewicz MJ; Toussaint ND; Polkinghorne KR
    Nephrology (Carlton); 2011 Mar; 16(3):261-8. PubMed ID: 21265930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease--mineral and bone disorder: a complex scenario.
    Mejía N; Roman-García P; Miar AB; Tavira B; Cannata-Andía JB
    Nefrologia; 2011; 31(5):514-9. PubMed ID: 21959717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
    Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
    J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of parathyroid hormone secretion and pathogenesis of secondary hyperparathyroidism].
    Komaba H
    Nihon Jinzo Gakkai Shi; 2014; 56(8):1201-9. PubMed ID: 25551980
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dialysis bone disease associated with secondary hyperparathyroidism].
    Nakazawa R
    Nihon Rinsho; 1992 Jan; 50 Suppl():783-8. PubMed ID: 1578767
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseases.
    Imanishi Y; Kobayashi K; Kawata T; Inaba M; Nishizawa Y
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S32-7. PubMed ID: 17976083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone and 1,25(OH)2D3 in chronic renal failure.
    Feinfeld DA; Sherwood LM
    Kidney Int; 1988 Jun; 33(6):1049-58. PubMed ID: 2841530
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathophysiological study on water electrolyte imbalance--special reference to calcium-phosphorus metabolism disorders].
    Ikeda K; Kawaguchi Y; Fukagawa M
    Nihon Naika Gakkai Zasshi; 2003 May; 92(5):737-42. PubMed ID: 12808895
    [No Abstract]   [Full Text] [Related]  

  • 12. [Secondary hyperparathyroidism].
    Nakanishi S; Fukagawa M
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():341-6. PubMed ID: 16279659
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progress in research on vitamin D].
    Michigami T; Ozono K
    Tanpakushitsu Kakusan Koso; 2006 Nov; 51(13):1836-46. PubMed ID: 17087354
    [No Abstract]   [Full Text] [Related]  

  • 14. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.
    Sato T; Tominaga Y; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Uchida K; Nakanishi S; Kazama JJ; Gejyo F; Yamashita T; Fukagawa M
    Am J Kidney Dis; 2004 Sep; 44(3):481-7. PubMed ID: 15332221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of the calcium-sensing receptor. Influence of secondary hyperparathyroidism].
    Fernández Martín JL; González Suárez I; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():7-11. PubMed ID: 12778846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary hyperparathyroidism in chronic kidney failure].
    Kalinin AP; Ivanov IA; Shcherbakova EO
    Ter Arkh; 1986; 58(8):143-8. PubMed ID: 3532407
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of calcium, calcitriol and their receptors in parathyroid regulation].
    Carrillo-López N; Fernández-Martín JL; Cannata-Andía JB
    Nefrologia; 2009; 29(2):103-8. PubMed ID: 19396314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor-23 and mineral metabolism after unilateral nephrectomy.
    Westerberg PA; Ljunggren O; Larsson TE; Wadström J; Linde T
    Nephrol Dial Transplant; 2010 Dec; 25(12):4068-71. PubMed ID: 20525976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of a phosphatonin in mineral homeostasis and its derangements.
    Bielesz B
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():34-42. PubMed ID: 16884396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of secondary hyperparathyroidism in chronic renal insufficiency.
    Portale AA; Morris RC
    Miner Electrolyte Metab; 1991; 17(4):211-20. PubMed ID: 1813783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.